Stage IV Endometrial Carcinoma Completed Phase 1 Trials for Carboplatin (DB00958)

IndicationStatusPhase
DBCOND0028761 (Stage IV Endometrial Carcinoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00004074Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuTreatment
NCT00408655Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid TumorsTreatment